Emergency paramedics seek approval to administer buprenorphine in overdose follow-up program

The recent government meeting in San Francisco focused on the challenges surrounding the administration of buprenorphine, a medication used to treat opioid addiction. A key point of discussion was the low connection rate for individuals needing this treatment, which stood at only 5 percent as of February.

Participants highlighted the complexities involved in administering buprenorphine, which can come in various forms, including a sublingual version. The process requires a physician's prescription and a pharmacist's involvement, creating barriers for individuals who may be in crisis, such as those recovering from an overdose or experiencing withdrawal symptoms.

Emergency room doctors often hesitate to prescribe buprenorphine due to concerns about follow-up care for patients. Many individuals transported by ambulance for overdoses do not receive adequate follow-up, complicating the treatment process. Advocates at the meeting expressed their commitment to bridging this gap by accompanying patients to hospitals and advocating for prescriptions, although this process can take several hours and is challenging for patients in distress.

In a positive development, the city has been approved for a state pilot program allowing community paramedics to carry and administer buprenorphine directly. However, operationalizing this initiative will require coordination with local and state emergency medical services and pharmacy groups, as well as establishing protocols with poison control for medical oversight.

The discussions underscored the urgent need for streamlined processes and better support systems to ensure individuals struggling with addiction can access the treatment they need effectively. Further meetings will be necessary to finalize the operational details of the new program.